Nr1i2 | nuclear receptor subfamily 1, group I, member 2
Physiological systems
20 / 24 physiological systems tested
2 Significantly impacted by the knock-out
Homeostasis/metabolism Hematopoietic system
18 No significant impact
4 Not tested
Data collections
Viability data
Body weight measurements
Embryo imaging data
Body weight measurements
Embryo imaging data
Gene metrics:3Significant phenotypes
0Associated diseases
Expression examined in:0Adult tissues
0Embryo tissues
| increased mean corpuscular volume | 1 supporting dataset | Nr1i2Nr1i2 | homozygote | Early adult | 1.73x10-7 | ||
| increased circulating creatinine level | 1 supporting dataset | Nr1i2Nr1i2 | homozygote | Early adult | 2.92x10-8 | ||
| increased circulating sodium level | 1 supporting dataset | Nr1i2Nr1i2 | homozygote | Early adult | 7.91x10-7 |
| | | | | | | | | | |
External links
No external links available for Nr1i2.
All available products are supplied via our member's centres or partnerships. When ordering a product from the IMPC you will be redirected to one of their websites or prompted to start an email.
| Nr1i2tm1(KOMP)Vlcg | Reporter-tagged deletion allele (with selection cassette) | | ES Cell |
| Nr1i2tm1a(EUCOMM)Wtsi | KO first allele (reporter-tagged insertion with conditional potential) | | targeting vector ES Cell |
| Nr1i2tm1e(EUCOMM)Wtsi | Targeted, non-conditional allele | | ES Cell |